Innovation

FogPharma: $145 Million Raised To Discover And Develop Helicon Therapeutics

By Amit Chowdhry ● Mar 4, 2024

FogPharma - a clinical-stage biopharmaceutical company dedicated to delivering a new class of therapies that go beyond the limits of currently available medicines using its Helicon peptide platform - announced the successful closing of a $145 million Series E financing round. And the funding was led by Nextech Invest with participation from other new investors including RA Capital Management, Rock Springs Capital, General Catalyst, Marshall Wace, Samsara Biocapital, Foresite Capital, Symbiosis, Catalio Capital Management, Sixty Degree Capital and former chairman and CEO of Johnson & Johnson, Alex Gorsky.

EasyKnock: Home Equity Solutions Company Raises $28 Million

By Amit Chowdhry ● Mar 4, 2024

Home equity solutions platform EasyKnock announced the completion of a $28 million Series D funding round. And Northwestern Mutual Future Ventures, the venture capital arm of Northwestern Mutual, a financial services company, join new and existing investors in the round.

Plant-Based Dog Food Brand PawCo Secures $2 Million

By Amit Chowdhry ● Mar 4, 2024

PawCo Foods - a plant-based pet nutrition brand dedicated to providing high-quality, sustainable, and scientifically-formulated food for dogs - announced a $2 million seed funding round led by Elevate Ventures, and other angel investors such as Arash Ferdowsi, co-founder of Dropbox. And with this funding round, PawCo will scale its operations by opening a second production facility (a midwest location to complement its current facility in California). And the brand will further invest in growth, research and development, new recipes and marketing tactics to drive awareness for the plant-based pet food category.

BlossomHill Therapeutics: $100 Million Raised To Address Unmet Medical Needs In Oncology And Autoimmune Diseases

By Amit Chowdhry ● Mar 4, 2024

BlossomHill Therapeutics - a biotechnology company focused on designing and developing small molecule medicines for treating cancer and autoimmune diseases - announced the closing of a $100 million Series B financing round. The funding was led by Colt Ventures with participation from new and existing investors, including Cormorant Asset Management, OrbiMed, Vivo Capital, Hercules BioVentures Partners LLC, Plaisance Capital Management LLC, and H&D Asset Management, and others.

Fervo Energy: Geothermal Development Company Raises $244 Million

By Amit Chowdhry ● Mar 4, 2024

Fervo Energy - a leader in next-generation geothermal development - announced that it had raised $244 million in new funding led by Devon Energy, a pioneer in shale oil and gas. And this funding will unlock Fervo’s next phase of growth, deploying proven technology adapted from the oil and gas industry at scale to deliver commercially viable 24/7 carbon-free energy.

Elda River Capital Management Completes Spin-Out From Magnetar

By Amit Chowdhry ● Mar 4, 2024

Elda River Capital Management recently announced its launch as an independent real assets-focused investment firm. Elda River launched with approximately $1.5 billion in assets under management in a spin-out from Magnetar and has offices in Houston, Texas; Evanston, Illinois; and London, United Kingdom.

Baseimmune: £9 Million In Funding Raised To Predict Future Pathogen Mutations To Generate Novel Vaccines

By Amit Chowdhry ● Mar 4, 2024

Baseimmune - a biotech company that uses proprietary, deep learning AI to predict future pathogen mutations to generate novel vaccines - recently announced the closing of £9 million in Series A funding led by new investors MSD Global Health Innovation Fund and IQ Capital, with participation from existing investors including Hoxton Ventures, Creator Fund, Beast Ventures and Maki.vc.

Prolocor: $1.7 Million Secured To Develop Precision Diagnostic Test To Predict Risks Of Thrombosis

By Amit Chowdhry ● Mar 4, 2024

Prolocor - a healthcare startup developing an innovative precision diagnostic test with the potential to predict the risk of thrombosis by quantifying FcγRIIa (pFCG test) - recently announced that they have successfully raised $1.7 million in bridge financing. The funding included significant participation by Green Park & Golf Ventures (GPG Ventures) and by the Labcorp Venture Fund.

Salvo Health: $5 Million Raised To Expand GI Provider Enablement for Wraparound Care

By Amit Chowdhry ● Mar 4, 2024

Salvo Health recently announced the closing of a $5 million Seed Prime round led by City Light Capital and Human Ventures to expand deployment of its wraparound GI care at providers including gastroenterology private practices, health systems, and ACOs.

NorthRock Partners Acquires Minkoff Wealth Partners And Opens SF Office

By Amit Chowdhry ● Mar 4, 2024

NorthRock Partners - a full-service financial and lifestyle advisory firm - announced it has opened its first office in California, acquiring San Francisco-based Minkoff Wealth Partners. This move also marks the firm’s first acquisition since announcing a formal partnership with Sammons Financial Group.

Orbis Medicines: Oral Macrocycle Drug Discovery Company Raises €26 Million

By Amit Chowdhry ● Mar 4, 2024

Orbis Medicines - a leader in oral macrocycle drug discovery - announced its launch with a €26 million financing led by global life sciences investor Novo Holdings and Forbion. These are the details.

Matter Neuroscience Secures $26 Million To Use Neuroscience To Help People Live Longer And Happier Lives

By Amit Chowdhry ● Mar 4, 2024

Matter Neuroscience, a company working to unlock a deeper understanding of happiness and well-being by providing people with personalized insights into their brain chemistry, recently emerged from stealth mode. And Matter announced it had received $26 million in funding, initial funding seeded by Polaris Partners and a more recent round co-led by ARCH Venture Partners, Polaris Partners, and Exor Ventures, and joined by Collaborative Fund and others. With this funding, Matter will bolster its efforts to pioneer solutions that address the unhappiness epidemic by transforming our understanding and management of mental well-being.